PDS Biotechnology Statistics

Total Valuation

FRA:EU6 has a market cap or net worth of EUR 33.78 million. The enterprise value is 26.70 million.

Market Cap	33.78M
Enterprise Value	26.70M

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	54.72M
Shares Outstanding	n/a
Shares Change (YoY)	+22.47%
Shares Change (QoQ)	+2.11%
Owned by Insiders (%)	2.58%
Owned by Institutions (%)	10.17%
Float	53.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.19
P/TBV Ratio	4.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.90
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 1.90.

Current Ratio	2.09
Quick Ratio	1.97
Debt / Equity	1.90
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.06

Financial Efficiency

Return on equity (ROE) is -221.81% and return on invested capital (ROIC) is -54.38%.

Return on Equity (ROE)	-221.81%
Return on Assets (ROA)	-46.22%
Return on Invested Capital (ROIC)	-54.38%
Return on Capital Employed (ROCE)	-150.77%
Revenue Per Employee	n/a
Profits Per Employee	-1.24M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-997,038
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-65.80%
50-Day Moving Average	0.79
200-Day Moving Average	1.04
Relative Strength Index (RSI)	38.56
Average Volume (20 Days)	2,909

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.47M
Pretax Income	-30.73M
Net Income	-29.73M
EBITDA	-27.42M
EBIT	-27.47M
Earnings Per Share (EPS)	-0.69

Full Income Statement

Balance Sheet

The company has 22.33 million in cash and 15.31 million in debt, giving a net cash position of 7.02 million.

Cash & Cash Equivalents	22.33M
Total Debt	15.31M
Net Cash	7.02M
Net Cash Per Share	n/a
Equity (Book Value)	8.06M
Book Value Per Share	0.17
Working Capital	12.41M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-27.52M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:EU6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.47%
Shareholder Yield	-22.47%
Earnings Yield	-88.01%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 18, 2019. It was a reverse split with a ratio of 0.05.

Last Split Date	Mar 18, 2019
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	2